Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
6.99
+0.01 (0.07%)
Mar 31, 2025, 1:17 PM EDT - Market open
Accolade Revenue
Accolade had revenue of $105.06M in the quarter ending November 30, 2024, with 5.73% growth. This brings the company's revenue in the last twelve months to $446.72M, up 14.99% year-over-year. In the fiscal year ending February 29, 2024, Accolade had annual revenue of $414.29M with 14.09% growth.
Revenue (ttm)
$446.72M
Revenue Growth
+14.99%
P/S Ratio
1.22
Revenue / Employee
$186,133
Employees
2,400
Market Cap
573.13M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ACCD News
- 3 days ago - Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewsWire
- 25 days ago - Accolade Welcomes Oshi Health to Trusted Partner Ecosystem - PRNewsWire
- 4 weeks ago - Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction - GlobeNewsWire
- 7 weeks ago - Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - PRNewsWire
- 2 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Accolade - PRNewsWire
- 2 months ago - ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD - Business Wire
- 2 months ago - Why Is Accolade Stock Trading Over 100% On Tuesday? - Benzinga
- 2 months ago - Healthcare M&A: Transcarent paying $621M to acquire Seattle-based health benefits firm Accolade - GeekWire